Samsung heir-medication case

▲ In this file photo, Samsung Electronics Co. Vice Chairman Lee Jae-yong arrives at the Seoul Central District Court on Aug. 26, 2021, to attend a hearing over his alleged stock manipulation. (Yonhap)

Samsung heir-medication case

Prosecutors demand 70 mln won fine for Samsung heir over illegal propofol use

SEOUL, Oct. 12 (Yonhap) -- Prosecutors on Tuesday demanded a 70 million won (US$58,300) fine for Samsung Group heir Lee Jae-yong over his alleged illegal use of propofol, an anesthesia-inducing medication.

In June, prosecutors indicted the Samsung Electronics Co. vice chairman on charges of taking propofol for purposes other than medical treatments.

In a hearing held at the Seoul Central District Court on Tuesday, prosecutors demanded the court hand Lee a 70 million fine and an additional forfeit of 17 million won.

Lee is suspected of having excessively and illegally taken the anesthesia drug at a plastic surgery clinic in Seoul from 2017-18. He has denied the allegation, arguing he used propofol "normally" in accordance with a doctor's prescription.

(END)
 

[Copyright ⓒ K-VIBE. All rights reserved. Unauthorized reproduction and redistribution are prohibited.]